Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Neuroscience|June 14, 2021
Altered Gut Microbiota in a Fragile X Syndrome Mouse ModelFrancisco Altimiras, José Antonio Garcia, Ismael Palacios-García, et al.
Pharmacology & Therapeutics|March 8, 2018
The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseasesMichael J Hurley, Robert M J Deacon, Katrin Beyer, et al.
Brain : a Journal of Neurology|July 1, 2021
Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome miceMichael J Hurley, Robert M J Deacon, A W Edith Chan, et al.
Neuromolecular Medicine|January 24, 2015
NNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndromeRobert M J Deacon, Larry Glass, Mike Snape, et al.
Scientific Reports|October 23, 2020
Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X micePatricia Cogram, Daniel L Alkon, David Crockford, et al.
Drug Testing and Analysis|September 27, 2014
Controlling the misuse of cobalt in horsesEmmie N M Ho, George H M Chan, Terence S M Wan, et al.
Brain Communications|November 13, 2023
α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an <i>in vitro</i> proof of concept studyMichael J Hurley, Elisa Menozzi, Sofia Koletsi, et al.
Iscience|August 16, 2024
Microbiome alterations are associated with apolipoprotein E mutation in <i>Octodon degus</i> and humans with Alzheimer's diseaseGuido Zampieri, Léa Cabrol, Claudio Urra, et al.
Frontiers in Aging Neuroscience|July 21, 2022
Genome Sequencing Variations in the <i>Octodon degus</i>, an Unconventional Natural Model of Aging and Alzheimer's DiseaseMichael J Hurley, Claudio Urra, B Maximiliano Garduno, et al.
Pageof 2